137 related articles for article (PubMed ID: 38142708)
1. Daily low-dose aspirin and incident type 2 diabetes in community-dwelling healthy older adults: a post-hoc analysis of efficacy and safety in the ASPREE randomised placebo-controlled trial.
Zoungas S; Zhou Z; Owen AJ; Curtis AJ; Espinoza SE; Ernst ME; Woods RL; Orchard SG; McNeil JJ; Murray AM; Nelson MR; Reid CM; Ryan J; Wolfe R
Lancet Diabetes Endocrinol; 2024 Feb; 12(2):98-106. PubMed ID: 38142708
[TBL] [Abstract][Full Text] [Related]
2. Effect of aspirin on deaths associated with sepsis in healthy older people (ANTISEPSIS): a randomised, double-blind, placebo-controlled primary prevention trial.
Eisen DP; Leder K; Woods RL; Lockery JE; McGuinness SL; Wolfe R; Pilcher D; Moore EM; Shastry A; Nelson MR; Reid CM; McNeil JJ; McBryde ES
Lancet Respir Med; 2021 Feb; 9(2):186-195. PubMed ID: 32950072
[TBL] [Abstract][Full Text] [Related]
3. Effect of Aspirin on Disability-free Survival in the Healthy Elderly.
McNeil JJ; Woods RL; Nelson MR; Reid CM; Kirpach B; Wolfe R; Storey E; Shah RC; Lockery JE; Tonkin AM; Newman AB; Williamson JD; Margolis KL; Ernst ME; Abhayaratna WP; Stocks N; Fitzgerald SM; Orchard SG; Trevaks RE; Beilin LJ; Donnan GA; Gibbs P; Johnston CI; Ryan J; Radziszewska B; Grimm R; Murray AM;
N Engl J Med; 2018 Oct; 379(16):1499-1508. PubMed ID: 30221596
[TBL] [Abstract][Full Text] [Related]
4. Aspirin and other non-steroidal anti-inflammatory drugs for the prevention of dementia.
Jordan F; Quinn TJ; McGuinness B; Passmore P; Kelly JP; Tudur Smith C; Murphy K; Devane D
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD011459. PubMed ID: 32352165
[TBL] [Abstract][Full Text] [Related]
5. Effect of Low-Dose Aspirin Versus Placebo on Incidence of Anemia in the Elderly : A Secondary Analysis of the Aspirin in Reducing Events in the Elderly Trial.
McQuilten ZK; Thao LTP; Pasricha SR; Artz AS; Bailey M; Chan AT; Cohen HJ; Lockery JE; Murray AM; Nelson MR; Schneider HG; Wolfe R; Woods RL; Wood EM; McNeil JJ
Ann Intern Med; 2023 Jul; 176(7):913-921. PubMed ID: 37335992
[TBL] [Abstract][Full Text] [Related]
6. Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial.
Wittert G; Bracken K; Robledo KP; Grossmann M; Yeap BB; Handelsman DJ; Stuckey B; Conway A; Inder W; McLachlan R; Allan C; Jesudason D; Fui MNT; Hague W; Jenkins A; Daniel M; Gebski V; Keech A
Lancet Diabetes Endocrinol; 2021 Jan; 9(1):32-45. PubMed ID: 33338415
[TBL] [Abstract][Full Text] [Related]
7. Low-Dose Aspirin and the Risk of Stroke and Intracerebral Bleeding in Healthy Older People: Secondary Analysis of a Randomized Clinical Trial.
Cloud GC; Williamson JD; Thao LTP; Tran C; Eaton CB; Wolfe R; Nelson MR; Reid CM; Newman AB; Lockery J; Fitzgerald SM; Murray AM; Shah RC; Woods RL; Donnan GA; McNeil JJ
JAMA Netw Open; 2023 Jul; 6(7):e2325803. PubMed ID: 37494038
[TBL] [Abstract][Full Text] [Related]
8. Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly.
McNeil JJ; Wolfe R; Woods RL; Tonkin AM; Donnan GA; Nelson MR; Reid CM; Lockery JE; Kirpach B; Storey E; Shah RC; Williamson JD; Margolis KL; Ernst ME; Abhayaratna WP; Stocks N; Fitzgerald SM; Orchard SG; Trevaks RE; Beilin LJ; Johnston CI; Ryan J; Radziszewska B; Jelinek M; Malik M; Eaton CB; Brauer D; Cloud G; Wood EM; Mahady SE; Satterfield S; Grimm R; Murray AM;
N Engl J Med; 2018 Oct; 379(16):1509-1518. PubMed ID: 30221597
[TBL] [Abstract][Full Text] [Related]
9. Daily Low-Dose Aspirin and Risk of Serious Falls and Fractures in Healthy Older People: A Substudy of the ASPREE Randomized Clinical Trial.
Barker AL; Morello R; Thao LTP; Seeman E; Ward SA; Sanders KM; Cumming RG; Pasco JA; Ebeling PR; Woods RL; Wolfe R; Khosla S; Hussain SM; Ronaldson K; Newman AB; Williamson JD; McNeil JJ
JAMA Intern Med; 2022 Dec; 182(12):1289-1297. PubMed ID: 36342703
[TBL] [Abstract][Full Text] [Related]
10. Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial.
Gaziano JM; Brotons C; Coppolecchia R; Cricelli C; Darius H; Gorelick PB; Howard G; Pearson TA; Rothwell PM; Ruilope LM; Tendera M; Tognoni G;
Lancet; 2018 Sep; 392(10152):1036-1046. PubMed ID: 30158069
[TBL] [Abstract][Full Text] [Related]
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness and Safety of Enteric-Coated vs Uncoated Aspirin in Patients With Cardiovascular Disease: A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial.
Sleem A; Effron MB; Stebbins A; Wruck LM; Marquis-Gravel G; Muñoz D; Re RN; Gupta K; Pepine CJ; Jain SK; Girotra S; Whittle J; Benziger CP; Farrehi PM; Knowlton KU; Polonsky TS; Roe MT; Rothman RL; Harrington RA; Jones WS; Hernandez AF
JAMA Cardiol; 2023 Nov; 8(11):1061-1069. PubMed ID: 37792369
[TBL] [Abstract][Full Text] [Related]
13. Effect of Aspirin on All-Cause Mortality in the Healthy Elderly.
McNeil JJ; Nelson MR; Woods RL; Lockery JE; Wolfe R; Reid CM; Kirpach B; Shah RC; Ives DG; Storey E; Ryan J; Tonkin AM; Newman AB; Williamson JD; Margolis KL; Ernst ME; Abhayaratna WP; Stocks N; Fitzgerald SM; Orchard SG; Trevaks RE; Beilin LJ; Donnan GA; Gibbs P; Johnston CI; Radziszewska B; Grimm R; Murray AM;
N Engl J Med; 2018 Oct; 379(16):1519-1528. PubMed ID: 30221595
[TBL] [Abstract][Full Text] [Related]
14. Study design of ASPirin in Reducing Events in the Elderly (ASPREE): a randomized, controlled trial.
ASPREE Investigator Group
Contemp Clin Trials; 2013 Nov; 36(2):555-64. PubMed ID: 24113028
[TBL] [Abstract][Full Text] [Related]
15. The Effect of Low-Dose Aspirin on Frailty Phenotype and Frailty Index in Community-Dwelling Older Adults in the ASPirin in Reducing Events in the Elderly Study.
Espinoza SE; Woods RL; Ekram ARMS; Ernst ME; Polekhina G; Wolfe R; Shah RC; Ward SA; Storey E; Nelson MR; Reid CM; Lockery JE; Orchard SG; Trevaks R; Fitzgerald SM; Stocks NP; Chan A; McNeil JJ; Murray AM; Newman AB; Ryan J
J Gerontol A Biol Sci Med Sci; 2022 Oct; 77(10):2007-2014. PubMed ID: 34758073
[TBL] [Abstract][Full Text] [Related]
16. Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline.
Ryan J; Storey E; Murray AM; Woods RL; Wolfe R; Reid CM; Nelson MR; Chong TTJ; Williamson JD; Ward SA; Lockery JE; Orchard SG; Trevaks R; Kirpach B; Newman AB; Ernst ME; McNeil JJ; Shah RC;
Neurology; 2020 Jul; 95(3):e320-e331. PubMed ID: 32213642
[TBL] [Abstract][Full Text] [Related]
17. Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study.
Zinman B; Harris SB; Neuman J; Gerstein HC; Retnakaran RR; Raboud J; Qi Y; Hanley AJ
Lancet; 2010 Jul; 376(9735):103-11. PubMed ID: 20605202
[TBL] [Abstract][Full Text] [Related]
18. Associations between blood sex steroid concentrations and risk of major adverse cardiovascular events in healthy older women in Australia: a prospective cohort substudy of the ASPREE trial.
Islam RM; Bell RJ; Handelsman DJ; McNeil JJ; Nelson MR; Reid CM; Tonkin AM; Wolfe RS; Woods RL; Davis SR
Lancet Healthy Longev; 2022 Feb; 3(2):e109-e118. PubMed ID: 35252940
[TBL] [Abstract][Full Text] [Related]
19. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial.
Bhatt DL; Steg PG; Mehta SR; Leiter LA; Simon T; Fox K; Held C; Andersson M; Himmelmann A; Ridderstråle W; Chen J; Song Y; Diaz R; Goto S; James SK; Ray KK; Parkhomenko AN; Kosiborod MN; McGuire DK; Harrington RA;
Lancet; 2019 Sep; 394(10204):1169-1180. PubMed ID: 31484629
[TBL] [Abstract][Full Text] [Related]
20. Misoprostol for small bowel ulcers in patients with obscure bleeding taking aspirin and non-steroidal anti-inflammatory drugs (MASTERS): a randomised, double-blind, placebo-controlled, phase 3 trial.
Taha AS; McCloskey C; McSkimming P; McConnachie A
Lancet Gastroenterol Hepatol; 2018 Jul; 3(7):469-476. PubMed ID: 29754836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]